A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects

Trial Profile

A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 14 May 2014

At a glance

  • Drugs Eravacycline (Primary)
  • Indications Intra-abdominal infections; Respiratory tract infections; Urinary tract infections
  • Focus Pharmacokinetics
  • Sponsors Tetraphase Pharmaceuticals
  • Most Recent Events

    • 14 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top